Navigation Links
CES 2017: SMI to Bring Eye Tracking to Standalone VR Devices
Date:1/4/2017

LAS VEGAS, January 4, 2017 /PRNewswire/ --

SMI's robust and reliable eye tracking demonstrated with the Qualcomm Snapdragon VR820 reference platform set the stage for a superior VR experience 

SensoMotoric Instruments (SMI), leaders in eye tracking technology, will bring robust and reliable eye tracking to future standalone virtual reality (VR) platforms as demonstrated with the Qualcomm® Snapdragon™ VR820 reference platform at CES® 2017.

Continue Reading
Qualcomm(R) Snapdragon[TM] VR820 reference platform with SMI eye tracking (PRNewsFoto/SensoMotoric Instruments GmbH (S)
Qualcomm(R) Snapdragon[TM] VR820 reference platform with SMI eye tracking (PRNewsFoto/SensoMotoric Instruments GmbH (S)

     (Photo: http://mma.prnewswire.com/media/453736/PRNE_SMI_Qualcomm_Image.jpg )

SMI eye tracking is a proven technology in computer and tablet screens, eye tracking glasses, and will help the next generation augmented reality (AR) and VR headsets - both standalone VR head mounted displays (HMDs) and smartphone slot-ins.

The Snapdragon VR820 reference platform is designed to allow customers to quickly develop standalone HMDs optimized for VR content and applications, while meeting the processing and performance demands of an all-in-one (AIO), dedicated VR headset.

"We believe that our eye tracking technology and Snapdragon reference platforms will have significant implications for the future of mobile standalone VR," said SMI Director OEM Business Christian Villwock. "The Snapdragon VR820 reference platform can help accelerate the development of new standalone VR devices and content, and our eye tracking technology is a key component for next generation products."

"With Qualcomm Technologies' great engineering support we have significantly optimized our technology, and we are confident we will be able to achieve even lower processing loads with shorter latency for the eye tracking. Both of these factors are expected to be instrumental in attaining the very best eye tracking performance in standalone VR," added Mr Villwock.

"Eye tracking is an important technology for the future of VR, as it can potentially improve immersion through more intuitive interactions and visual quality enhancements when paired with Snapdragon processors," said Hugo Swart, senior director, product management, Qualcomm Technologies, Inc. "Eye tracking has a roadmap of benefits in mobile and standalone VR headsets. Gaze interaction, social presence, foveated rendering, personal display calibration and analytical insights are all potential uses that OEMs and application developers will be able to utilize."

Mr Villwock concluded: "Eye tracking is set to become a 'must have' in VR systems. We are proud to work with Qualcomm Technologies, a leader in VR and AR, to bring these benefits to the mobile VR community of the future."

SMI's eye tracking technology, working along the Snapdragon VR820 platform, will be demonstrated at the Qualcomm Technologies booth at CES, Central Hall #10948.

About SMI 

SensoMotoric Instruments (SMI) has been a world leader in eye tracking technology for 25 years, developing and marketing eye & gaze tracking systems for scientists and professionals, as well as OEM and medical solutions for a wide range of applications. Find out more at http://www.smivision.com. Follow @SMIeyetracking on Facebook, Flickr, YouTube and Twitter.

Media Contacts
SensoMotoric Instruments GmbH (SMI)
Tim Stott
+49 (0) 162 271 61 66
tim.stott@smi.de

###
Qualcomm Technologies, Inc. is a subsidiary of Qualcomm Incorporated. Qualcomm and Snapdragon are trademarks of Qualcomm Incorporated, registered in the United States and other countries. Other product and brand names may be trademarks or registered trademarks of their respective owners.
Qualcomm Snapdragon is a product of Qualcomm Technologies, Inc.



'/>"/>
SOURCE SensoMotoric Instruments GmbH (SMI)
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. European Home Healthcare Market Report 2013-2017: Products, Services & Telehealth
2. Global Healthcare/Medical Simulation Market Repor 2013-2017: By Product, Technology, End-Users & Services Analysis
3. Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research
4. United States Market Report for Detachable Coils 2017: Trials such as the MAPS and Cerecyte failed to show a superior efficacy for coated coils over bare platinum coils - Research and Markets
5. United States Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices Market Overview 2017: Stereotaxy has Become the Standard of Care - Research and Markets
6. United States Intracranial Pressure Monitoring Devices Market Report 2017: Internal and External Transducers are Expected to Experience Steady Growth - Research and Markets
7. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
8. Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt
9. Hepatitis Awareness: Bringing Attention to a Silent Epidemic
10. The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
11. BioElectronics Continues FDA Clearance Campaign to Bring Chronic Pain Sufferers Safe, Effective, Inexpensive, Drug-Free Pain Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... is a revolutionary new product that relieves painful carpal tunnel syndrome ... affects more than 8 million people a year. Women suffer from ... methods of treating CTS are painful surgery, the use of NSAIDs ... ... a clear patch worn on the palm of the hand. It ...
(Date:7/11/2017)... Research Corp., also known as ,The Epigenetics Company, announced today the release ... manner using the myDNAge ™ test. Based on Horvath,s Clock, so ... and biostatistics at the David Geffen School of Medicine at UCLA ... DNAge ™ technology is used to analyze DNA methylation patterns of ... ...
(Date:7/11/2017)...  The global market for liquid biopsy diagnostic and ... in 2016.  Although in early stages, the global market ... as a result of the gradual shift towards personalized ... of a significant number of new liquid biopsy tests ... biomarkers to guide treatment decisions. ...
Breaking Medicine Technology:
(Date:7/25/2017)... , ... July 25, 2017 , ... ... announce the launch of their partnership to provide the Pharmacist eCare Plan ... pharmacy-focused platform in the country with the ability to develop the Pharmacist eCare ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... director. Dr. Negrette has more than a decade of experience in psychiatry, treating ... with individuals fighting addictions, eating disorders, psychotic and manic conditions, as well as ...
(Date:7/24/2017)... JACKSONVILLE, Florida (PRWEB) , ... ... ... Klaproth, Division Marketing Director,      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins ... guests joined together to celebrate the structural topping out of the new ...
(Date:7/24/2017)... ... 24, 2017 , ... Horizon Goodwill Industries, SourceAmerica ... helps high school girls succeed in STEM programs as well as help Horizon ... host over 20 high school girls at their corporate headquarters on Tuesday, July ...
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a leading provider of ... with WALLIX to expand its solution to help government contractors more quickly ... number of ways to address the authentication requirements within NIST SP800-171, but no ...
Breaking Medicine News(10 mins):